Ophthalmic AI Advantage Avellino's AI-powered genetic analytics deliver personalized eye disease risk predictions and progression prevention, creating a compelling value proposition for ophthalmology networks and payers. This can be leveraged to license or co-develop diagnostic tools, integrate into EHR and clinic workflows, and scale across regions where Avellino operates. The CLIA-certified lab and established testing capacity support high reliability and rapid deployment.

Global Expansion Readiness With operations in the United States, Korea, Japan and the United Kingdom and a commitment to diverse study populations, Avellino offers multiple entry points for regional partnerships. Sales opportunities include regional distributors, CRO collaborations, and health system procurements, supported by regulatory guidance, data governance, and localized support offerings.

High-Volume Lab Capabilities Avellino runs a high-capacity, CLIA-certified laboratory focused on infectious disease testing, creating a strong foundation for outsourced testing for clinical trials, population screening, and diagnostic development. Potential upsell to biopharma and CROs for trial screening services, and to hospitals and clinics for rapid diagnostic programs with integrated data feeds.

Cloud Genomics Platform The tech stack including leading cloud providers and devops tools positions Avellino to offer a secure, scalable cloud based genomics analytics platform with managed machine learning pipelines and data integration. Target biotech and pharma firms seeking AI driven discovery, real world evidence analytics, and turnkey deployment with compliance and data security features.

Diverse Genomics Partnerships Avellino prioritizes health equity through diverse population enrollment, opening opportunities to co-develop inclusive genomic datasets and population specific risk models. Partnerships can focus on pharma and diagnostics sponsors seeking representative data, regulatory ready analytics, and co development of precision medicine solutions with a social impact narrative.